Abstract

Abstract Interim analysis of accumulating data in a clinical trial is now an established practice for ethical and scientific reasons. Repeatedly testing interim data can inflate false positive error rates if not handled appropriately. Group sequential methods are a commonly used frequentist approach to control this error rate. Motivated by experience of clinical trials, the alpha spending function is one way to implement group sequential boundaries that control the type I error rate while allowing flexibility in how many interim analyses are to be conducted and at what times. In this paper, we review the alpha spending function approach, and detail its applicability to a variety of commonly used statistical procedures, including survival and longitudinal methods.

Keywords

InterimFrequentist inferenceInterim analysisFlexibility (engineering)Type I and type II errorsComputer scienceFunction (biology)EconometricsStatisticsClinical trialMedicineMathematicsBayesian probabilityBayesian inference

MeSH Terms

BiasClinical Trials as TopicData InterpretationStatisticalDouble-Blind MethodHumansLongitudinal StudiesMulticenter Studies as TopicMyocardial InfarctionPropranololRandomized Controlled Trials as TopicSurvival Analysis

Affiliated Institutions

Related Publications

A Direct Approach to False Discovery Rates

Summary Multiple-hypothesis testing involves guarding against much more complicated errors than single-hypothesis testing. Whereas we typically control the type I error rate for...

2002 Journal of the Royal Statistical Soci... 5607 citations

Publication Info

Year
1994
Type
article
Volume
13
Issue
13-14
Pages
1341-1352
Citations
547
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

547
OpenAlex
20
Influential
436
CrossRef

Cite This

David L. DeMets, K. K. Gordon Lan (1994). Interim analysis: The alpha spending function approach. Statistics in Medicine , 13 (13-14) , 1341-1352. https://doi.org/10.1002/sim.4780131308

Identifiers

DOI
10.1002/sim.4780131308
PMID
7973215

Data Quality

Data completeness: 81%